omposition |
Each Tablet Contains: Each tablet contains 0.5µg Alfacalcidol. |
Pack |
2 x 10's |
Therapeutic Classification |
Vitamin D Analogue (Active form of Vitamin D3) |
Prescribing Information |
| Indications: CADLA is used for treating disturbances in the calcium metabolism due to impaired 1-hydroxylation that happens due to insufficient renal function, osteoporosis and disorders related with vitamin D deficiencies such as: - Osteoporosis - Renal osteodystrophy - Hyperparathyroidism associated with bone disease - Idiopathic and postoperative hypoparathyroidism - Nutritional and malabsorption rickets and osteomalacia - Hypophosphataemic vitamin D resistant rickets and osteomalacia - Pseudo deficiency (D Dependent Type I) rickets with osteomalacia Contraindications: CADLA should not be given to patients with hypercalcemia, hyperphosphataemia (except due to hypoparathyroidism), hypermagnesaemia or evidence of vitamin D toxicity. Precautions: Throughout the treatment with CADLA regular serum calcium determinations are essential. |
No comments:
Post a Comment